COVID-19, antiviral drug, nucleoside analog, mutagenesis, animal model, HAE
molnupiravir, favipiravir, nirmatrelvir, Inflammasome, VX-765, COVID-19, Convalescent Plasma, Bioluminescence imaging, Delta, Omicron, K18-hACE2